Immunocompromised patients in a multi-profile hospital
https://doi.org/10.18093/0869-0189-2017-27-3-392-397
Abstract
The aim of this study was to describe immunocompromised patients admitted in a multi-profile hospital. Methods. Risk factors, morbidity, treatment, prevention and mortality of immunocompromised patients were analyzed. Results. Immunocompromised patients included patients with primary immunodeficiency, diabetes mellitus, kidney transplant recipients, Crohn’s disease and patients treated with immunosupressors. Patients generally had moderate to severe course of the disease. Conclusion. The proportion of immunocompromised patients in a multi-profile hospital as high as 80%. Infectious complications and prevention of infections is important in those patients and require additional analysis.
About the Authors
Marina L. Karakina
Sverdlovsk State Regional Clinical Hospital No.1
Russian Federation
Candidate of Medicine, an allergist and immunologist, Sverdlovsk State Regional Clinical Hospital No.1; tel.: (343) 351-15-85;
Russian Federation
Candidate of Medicine, an allergist and immunologist, Sverdlovsk State Regional Clinical Hospital No.1; tel.: (343) 351-15-85;
Nataliya F. Klimusheva
Sverdlovsk State Regional Clinical Hospital No.1
Russian Federation
Candidate of Medicine, Deputy Director for Clinical Care, Sverdlovsk State Regional Clinical Hospital No.1; tel.: (343) 351-16-16;
Russian Federation
Candidate of Medicine, Deputy Director for Clinical Care, Sverdlovsk State Regional Clinical Hospital No.1; tel.: (343) 351-16-16;
Tat'yana V. Chernova
Ural State Academic and Practical Center of Medical, Social and Economic Healthcare Problems
Russian Federation
Doctor of Medicine, Professor, Deputy Director for Education, Ural State Academic and Practical Center of Medical, Social and Economic Healthcare Problems; tel.: (343) 287-57-36;
Russian Federation
Doctor of Medicine, Professor, Deputy Director for Education, Ural State Academic and Practical Center of Medical, Social and Economic Healthcare Problems; tel.: (343) 287-57-36;
References
1. Rich R.R., Fleisher T.A., Shearer W.T. et al. Clinical Immunology: Principles and Practice. 4th Ed. Elsevier; 2013.
2. Chear C.T., Ripen A.M., Mohamed S.A., Dhaliwal J.S. A novel BTK gene mutation creates a de-novo splice site in an X-linked agammaglobulinemia patient. Gene. 2015; 560 (2): 245–253. DOI: 10.1016/j.gene.2015.02.019.
3. Hacein-Bey-Abina S., Hauer J., Lim A. et al. Efficacy of gene therapy for X-linked severe combined immunodeficiency. N. Engl. J. Med. 2010; 363 (4): 355–419. DOI: 10.1056/NEJMoa1000164.
4. Audemard-Verger A., Descloux E., Ponard D. et al. Infections Revealing complement deficiency in adults: A french nationwide study enrolling 41 patients. Medicine (Baltimore). 2016; 95 (19): 1–4. DOI: 10.1097/MD.0000000000003548.
5. Gokengin D., Oprea C., Uysal S., Begovac J. The growing HIV epidemic in Central Europe: a neglected issue? J. Virus Erad. 2016; 2 (3): 156–217.
6. Pruetpongpun N., Khawcharoenporn T., Damronglerd P. et al. Disseminated talaromyces marneffei and Mycobacterium abscessus in a patient with anti-interferon-#g autoantibodies. Open Forum Infect Dis. 2016; 3 (2): 1–4. DOI: 10.1093/ofid/ofw093.
7. Got'e S.V., Moysyuk Ya.G., Khomyakov S.M. Organ donation and transplantation in Russian Federation in 2014. The 7th Report of Russian Transplantology Society Register. Vestnik transplantologii i iskusstvennykh organov. 2015; 17 (2): 7–22. DOI: 10.15825/1995-1191-2015-2-7-22 (in Russian).
8. Got'e S.V., Khomyakov S.M. An evaluation of population's need in organ transplantation and donor resources, and scheduled efficacy of transplantation centers. Vestnik transplantologii i iskusstvennykh organov. 2013; (3): 11–24 (in Russian).
9. Burroughs M., Moscona A. Immunization of pediatric solid organ transplant candidates and recipients. Clin. Infect. Dis. 2000; 30 (6): 857–869. DOI: 10.1086/313823.
10. Rubin L.G., Levin M.J., Ljungman P. et al. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin. Infect. Dis. 2014: 58 (3): 309–318. DOI: 10.1093/cid/cit816.
11. Heijstek M.W., Ott de Bruin L.M., Bijl M. et al. EULAR recommendations for vaccination in paediatric patients with rheumatic diseases. Ann. Rheum. Dis. 2011; 70 (10): 1704–1712. DOI: 10.1136/ard.2011.150193.
12. Harpaz R., Ortega-Sanchez I.R., Seward J.F. Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep. 2008; 57 (RR-5): 1–30.
13. Ostrovskiy Yu.P., Rachok L.V., Grebenyuk I.A. et al. Infectious complications in orthotopic heart transplantation survivors. Vestnik transplantologii i iskusstvennykh organov. 2011; (4): 24–31 (in Russian).
14. Bilichenko T.N., Argunova A.N., Antonova O.A. et al. Prevalence of pneumococcal pneumonia in adult patients of therapeutic hospitals at three regions of Russian Federation. Pul'monologiya. 2013; (4): 30–36 (in Russian).
15. WHO statement on polysaccharide pneumococcal vaccination. Ezhenedel'nyy epidemiologicheskiy byulleten'. 2008; 83 (42): 373–384 (in Russian).
16. Moberley S., Holden J., Tatham D.P., Andrews R.M. Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst. Rev. 2008; (1): CD000422.
17. Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23 valent pneumococcal polysaccharide vaccine (PPSV23). Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep. 2010; 59 (34): 1102–1106.
18. Karakina M.L. A register of adult patients with primary immunodeficiency at Sverdlovsk region. Obshchestvennoe zdorov'e i zdravookhranenie. 2016; (1); 57–63 (in Russian).
19. Vinogradov A.V., Bel'tyukov E.K., Karakina M.L. et al. An experience of personalized medical care for patients with primary immunodeficiency at Sverdlovsk region. Ural'skiy meditsinskiy zhurnal. 2014; 6 (120): 31–34 (in Russian).
20. Bel'tyukov E.K., Vinogradov A.V., Tuzankina I.A., Karakina M.L. About management of specialized allergology and immunology care for adult population of Sverdlovsk region. Rossiyskiy immunologicheskiy zhurnal. 2014; (3): 482–483 (in Russian).
21. Vinogradov A.V., Bel'tyukov E.K., Karakina M.L., Chadova E.A. Healthcare management for adults with primary immunodeficiency and antibody production defects in Sverdlovsk region. Ural'skiy meditsinskiy zhurnal, 2015; 9: 57–60 (in Russian).
22. Shearer W.T., Fleisher A., Buckley R.H. et al. Recommendations for live viral and bacterial vaccines in immunodeficient patients and their close contacts. J. Allergy Clin. Immunol. 2014; 133 (4): 961–966. DOI: 10.1016/j.jaci.2013.11.043.
23. Aguilar C., Malphettes M., Donadieu J. et al. Prevention of infections during primary immune deficiencies. Immunocompromised Hosts. Clinical Infectious Diseases Advance Access published September 28, 2014. Available at: http://cid.oxfordjournals.org
24. Snegova N.F., Kharit S.M., Lyanko L.M. General approach to immunization of children with primary immunodeficiency. Byulleten' «Vaktsinatsiya. Novosti vaktsinoprofilaktiki». Immunodefitsity. 2003; 6 (30): 32–35 (in Russian).
25. International Diabetes Federation Diabetes Atlas, 5th ed. Brussels; 2011. Available at: http://www.idf.org/diabetesatlas
26. Kornum J.B., Thomsen R.W., Riis A. et al. Type 2 diabetes and pneumonia outcomes: A population-based cohort study. Diabetes Care. 2007; 30 (9): 2251–2257. DOI: 10.2337/dc06-2417.
27. Smith S.A., Poland G.A. Use of influenza and pneumococcal vaccines in people with diabetes. Diabetes Care. 2000; 23 (1): 95–108.
28. Fiore A.E., Shay D.K., Broder K. et al. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep. 2008; 57 (RR-7): 1–60.
29. American Diabetes Association. Standards of Medical Care in Diabetes, 2012. Diabetes Care. 2012; 35 (Suppl. 1): S11-S63. DOI: 10.2337/dc12-s011.
30. Oshchepkov A.V., Tsaur G.A., Eseva S.S. et al. Epidemiological aspects of Crohn’s disease at Sverdlovsk region. Vestnik ural'skoy meditsinskoy akademicheskoy nauki. 2015; (3): 36–38 (in Russian).
Review
For citations:
Karakina M.L., Klimusheva N.F., Chernova T.V. Immunocompromised patients in a multi-profile hospital. PULMONOLOGIYA. 2017;27(3):392-397. (In Russ.) https://doi.org/10.18093/0869-0189-2017-27-3-392-397
Views:
7051
Email this article 